Ying-Jun Chang Selected Research

Ying-Jun Chang Research Topics

Disease

28	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 10/2007
24	Leukemia 01/2022 - 10/2007
22	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 10/2007
21	Residual Neoplasm 06/2022 - 07/2012
18	Infections 01/2022 - 07/2012
18	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 06/2012
12	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2021 - 01/2018
8	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 11/2017
7	Hematologic Diseases (Blood Diseases) 01/2022 - 08/2009
7	Bronchiolitis Obliterans Syndrome 01/2022 - 01/2011
5	Thrombocytopenia (Thrombopenia) 12/2021 - 08/2014
5	Neoplasms (Cancer) 12/2021 - 04/2011
4	Multiple Myeloma 06/2022 - 04/2011
4	Philadelphia Chromosome 11/2021 - 01/2018
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2019 - 10/2015
3	Thrombotic Microangiopathies 01/2022 - 02/2018
3	Hemorrhage 01/2022 - 01/2021
3	Pneumonia (Pneumonitis) 10/2021 - 11/2020
3	Aplastic Anemia (Anemia, Hypoplastic) 01/2019 - 01/2018
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2015 - 10/2009
2	Cytomegalovirus Infections (Inclusion Disease) 01/2022 - 11/2017
1	Anemia 12/2021
1	Proteinuria 12/2021
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 06/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Acute Cholecystitis 01/2021
1	Ischemic Stroke 11/2020
1	Encephalitis (Encephalitis, Rasmussen) 11/2020
1	Retinitis 11/2020
1	Stroke (Strokes) 11/2020
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 11/2020
1	Gastroenteritis 11/2020
1	Posterior Leukoencephalopathy Syndrome 10/2020
1	Pancytopenia 03/2020
1	Tuberculosis (Tuberculoses) 01/2020
1	Pancreatitis 01/2020
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 07/2019
1	Guillain-Barre Syndrome 01/2019
1	Disease Progression 01/2019
1	Polyneuropathies (Polyneuropathy) 01/2019
1	Viremia 01/2019
1	Hepatitis 01/2019

Drug/Important Bio-Agent (IBA)

14	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020 - 08/2009
8	Inosine Triphosphate (ITP)IBA 01/2022 - 11/2017
8	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022 - 10/2007
6	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 10/2020 - 12/2012
4	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2020
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2016
4	Immunoglobulin G (IgG)IBA 01/2019 - 07/2012
3	Chimeric Antigen ReceptorsIBA 06/2022 - 01/2018
3	AntibodiesIBA 06/2022 - 01/2019
3	InterferonsIBA 01/2022 - 01/2021
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 10/2020 - 01/2019
3	Prostaglandins FIBA 03/2020 - 10/2015
3	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 12/2012
2	Indicators and Reagents (Reagents)IBA 01/2022 - 08/2020
2	BilirubinIBA 01/2022 - 12/2021
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2016
2	AntigensIBA 11/2021 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2020
2	Messenger RNA (mRNA)IBA 08/2020 - 05/2018
2	LigandsIBA 12/2019 - 01/2017
2	HLA-B Antigens (HLA-B)IBA 01/2019 - 01/2018
2	GlucocorticoidsIBA 01/2019 - 07/2012
2	HLA-A Antigens (HLA-A)IBA 01/2019 - 01/2018
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017 - 12/2012
1	Immunomodulating AgentsIBA 06/2022
1	Proteasome InhibitorsIBA 06/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022
1	Prednisone (Sone)FDA LinkGeneric 01/2022
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022
1	Basiliximab FDA Link 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2021
1	olaratumabIBA 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	CytokinesIBA 01/2021
1	Nuclear Pore Complex Proteins (Nucleoporins)IBA 12/2020
1	Methotrexate (Mexate)FDA LinkGeneric 10/2020
1	thymoglobulin FDA Link 10/2020
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2020
1	NucleophosminIBA 01/2020
1	Insulin-Like Growth Factor Binding Protein 3IBA 01/2019
1	SteroidsIBA 01/2019
1	HLA-DR Antigens (HLA-DR)IBA 01/2019

Therapy/Procedure

51	Hematopoietic Stem Cell Transplantation 01/2022 - 10/2007
38	Transplantation 01/2022 - 03/2008
25	Stem Cell Transplantation 06/2022 - 10/2011
10	Therapeutics 06/2022 - 04/2017
9	Haploidentical Transplantation 01/2021 - 11/2009
5	Donor Selection 01/2021 - 04/2016
5	Cell Transplantation 01/2020 - 10/2014
5	Drug Therapy (Chemotherapy) 01/2020 - 06/2012
5	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2018 - 03/2012
4	Immunotherapy 06/2022 - 01/2013
2	Platelet Transfusion (Blood Platelet Transfusions) 01/2021 - 11/2020
1	Plasma Exchange 01/2022
1	Aftercare (After-Treatment) 01/2021
1	Total Parenteral Nutrition 01/2021